Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure

Journal of the American College of Cardiology

Volumn 42, Issue 5, 2003, Pages 861-868

  Gielen, Stephan ^a   Adams, Volker ^a   Möbius Winkler, Sven ^a   Linke, Axel ^a   Erbs, Sandra ^a   Yu, Jiangtao ^a   Kempf, Werner ^c   Schubert, Andreas ^b   Schuler, Gerhard ^a   Hambrecht, Rainer ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Klinik fur Herzchirurgie   (Germany)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE; MALE; MUSCLE BIOPSY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE;

EID: 20244363895     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(03)00848-9     Document Type: Article

References (28)

1. Orus J, Roig E, Perez-Villa F, et al. Prognostic value of serum cytokines in patients with congestive heart failure. J Heart Lung Transplant 2000;19:419-25.
2. Anker S, Clark AL, Kemp M, et al. Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting. J Am Coll Cardiol 1997;30:997-1001.
3. Anker SD, Ponikowski PP, Leyva F, et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur Heart J 1999;20:683-93.
4. Niebauer J, Pflaum CD, Clark AL, et al. Deficient insulin-like growth factor 1 in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation. J Am Coll Cardiol 1998;32:393-7.
5. Torre-Amione G, Kapadia SR, Benedict C, Oral H, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies Of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 1996;27:1201-6.
6. McTiernan CF, Lemster BH, Frye C, Brooks S, Combes A, Feldman AM. Interleukin-1-beta inhibits phospholamban gene expression in cultured cardiomyocytes. Circ Res 1997;81:493-503.
7. Li N, Karin M. Is NF-kB the sensor of oxidative stress? FASEB J 1999;13:1137-43.
8. Riede U, Förstermann U, Drexler H. Inducible nitric oxide synthase in skeletal muscle of patients with chronic heart failure. J Am Coll Cardiol 1998;32:964-9.
9. Hambrecht R, Adams V, Gielen S, et al. Exercise intolerance in patients with chronic heart failure and increased expression of inducible nitric oxide synthase in the skeletal muscle. J Am Coll Cardiol 1999;33:174-9.
10. Sullivan MJ, Higginbotham MB, Cobb FR. Exercise training in patients with severe left ventricular dysfunction: hemodynamic and metabolic effects. Circulation 1988;78:506-15.
11. Coats AJS, Adamopoulos S, Meyer TE, Conway J, Sleight P. Effects of physical training in chronic heart failure. Lancet 1990;335:63-6.
12. Wassermann K, Whipp BJ, Koyal SH, Beaver WL. Anaerobic threshold and respiratory gas exchange during exercise. J Appl Physiol 1973;35:236-43.
13. Bachmaier K, Neu N, Pummerer C, et al. iNOS expression and nitrotyrosine formation in the myocardium in response to inflammation is controlled by the interferon regulatory transcription factor 1. Circulation 1997;96:585-91.
14. Testa M, Yeh M, Lee P, et al. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol 1996;28:964-71.
15. Lommi J, Koskinen P, Näveri H, Leinonen H, Härkönen M, Kupari M. Haemodynamic, neuroendocrine and metabolic correlates of circulating cytokine concentrations in congestive heart failure. Eur Heart J 1997;18:1620-5.
16. Adamopoulos S, Parissis J, Kroupis C, et al. Physical training reduces peripheral markers of inflammation in patients with chronic heart failure. Eur Heart J 2001;22:791-7.
17. Mancini DM, Walter G, Reichek N, et al. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 1992;85:1364-73.
18. Simonini A, Long CS, Dudley GA, Yue P, McElhinny J, Massie BM. Heart failure in rats causes changes in skeletal muscle morphology and gene expression that are not explained by reduced activity. Circ Res 1996;79:128-36.
19. McMurray J, Abdullah I, Dargie HJ, Shapiro D. Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure. Br Heart J 1991;66:356-8.
20. Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA. The expression of TNF-alpha by human muscle - relationship to insulin resistance. J Clin Invest 1996;97:1111-6.
21. Paulus WJ. How are cytokines activated? Eur J Heart Fail 1999;1:309-12.
22. Yamashita N, Hoshida S, Otsu K, Asahi M, Kuzuya T, Hori M. Exercise provides direct biphasic cardioprotection via manganese superoxide dismutase activation. J Exp Med 1999;189:1699-706.
23. Powers SK, Criswell D, Lawler J, et al. Influence of exercise and fiber type on antioxidant enzyme activity in rat skeletal muscle. Am J Physiol 1994;266:R375-80.
24. Ennezat PV, Malendowicz LS, Testa M, et al. Physical training in patients with chronic heart failure enhances the expression of genes antioxidative enzymes. J Am Coll Cardiol 2001;38:194-8.
25. Hambrecht R, Gielen S, Linke A, et al. Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure: a randomised trial. JAMA 2000;283:3095-101.
26. Fukai T, Siefried MR, Fukai M, Cheng Y, Kojda G, Harrison DG. Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training. J Clin Invest 2000;105:1631-9.
27. Adams V, Nehrhoff B, Späte U, et al. Induction of iNOS-expression in skeletal muscle by IL-1-beta and NF-kappa-B activation: an in vitro and in vivo study. Cardiovasc Res 2002;54:95-104.
28. Punzalan C, Cai C, Schroeder RA, Kuo PC. Redox regulation of the rat hepatocyte iNOS promoter. Surgery 1999;126:450-5.